By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.




Founders: August Krogh and Marie Krogh

CEO: Lars Rebien Sørensen

CFO: Jesper Brandgaard

CSO (Scientific): Mads Krosgsgaard Themsen


Please click here for Novo Nordisk job opportunities.


Please click here for clinical trial information.


Key Statistics

Ownership: Public

Web Site: Novo Nordisk A/S
Employees: 13395
Symbol: NVO

Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Maxygen, Inc. 

Intergen Company 

Company News
Novo Nordisk A/S (NVO) Files For Regulatory Approval Of Once-Weekly Semaglutide With The FDA For The Treatment Of Type 2 Diabetes 12/5/2016 8:29:35 AM
Novo Nordisk A/S (NVO) Yanks Ads Off of Conservative Site Founded by Trump's New Chief Strategist Stephen Bannon 11/28/2016 6:44:17 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Xultophy 100/3.6 (Insulin Degludec And Liraglutide Injection) 11/22/2016 6:53:10 AM
How Drug Price Pressure Helped Sink Novo Nordisk A/S (NVO)'s Insulin Pill 11/17/2016 7:30:05 AM
Novo Nordisk A/S (NVO) Expands Programme To Reach 20,000 Children With Diabetes In Developing Countries 11/15/2016 8:40:40 AM
Bernie Sanders Asks the DOJ to Investigate Eli Lilly (LLY), Novo Nordisk A/S (NVO) and Sanofi (SNY) 11/7/2016 6:38:20 AM
Novo Nordisk A/S (NVO) Release: New Study Showed That Only 55% Of People With Obesity Have Received A Formal Obesity Diagnosis 11/3/2016 7:26:20 AM
Novo Nordisk A/S (NVO) Release: New Data Show Post-Meal Hyperglycaemia Is Associated With A Negative Impact On Quality Of Life For People With Diabetes 11/1/2016 8:41:11 AM
Novo Nordisk A/S (NVO) Bids Adieu to Oral Insulin, Shakes Up R&D for Growth 11/1/2016 6:18:45 AM
Society For Clinical Research Sites Announces Winning Sponsor And CRO Of 2016 Eagle Award – Novo Nordisk A/S (NVO) And QuintilesIMS 10/18/2016 10:11:36 AM